LITTLE FALLS, N.J.,
Jan. 15, 2015 /PRNewswire/
-- Mar Cor Purification, Inc. (Mar Cor), a subsidiary of
Cantel Medical Corp. (NYSE:CMN) announced today that it has
been given 510(k) clearance (K133724) from the FDA for MINNCARE® HD
high level disinfectant, the first water system disinfectant
granted a medical device clearance for use in hemodialysis
applications. MINNCARE HD disinfectant is a proprietary blend
of peracetic acid and hydrogen peroxide and is completely
biodegradable allowing for easy disposal and reducing environmental
impact. The non-medical device version, MINNCARE® Cold
Sterilant, is considered the gold standard in water system
disinfection and is used daily in a variety of markets and
applications.
MINNCARE HD disinfectant was developed to address the critical
need for a validated water system disinfectant that is both safe
and effective. After developing an effective protocol with
the FDA, Mar Cor successfully conducted extensive testing to
validate product performance and safety. Together with
MINNCARE HD disinfectant, Mar Cor will offer validated test strips
for testing strength and to verify that there are no residuals
following a disinfection procedure. Both products will be available
in early February 2015.
John Rickert, VP Medical Sales,
noted, "MINNCARE HD disinfectant eliminates the risk of using
unregulated industrial chemicals, such as chlorine bleach, in
patient treatment areas. The disinfection protocol is
validated, the chemistry has been proven efficacious, and accurate
test strips are available to insure dosage, as well as to verify
complete rinse-out of the disinfectant. The use of MINNCARE
HD disinfectant in a dialysis clinic will help maintain the water
system in optimum condition and make it easier for the water system
operator to complete an effective disinfection."
MINNCARE® is a registered trademark of Medivators Inc. (a Cantel
Medical Company)
About Cantel Medical Corp.
Cantel Medical Corp.
(NYSE:CMN) Cantel Medical is a leading global company dedicated to
delivering innovative infection prevention and control products and
services for patients, caregivers, and other healthcare providers
which improve outcomes, enhance safety and help save lives.
Our products include specialized medical device reprocessing
systems for endoscopy and renal dialysis, advanced water
purification equipment, sterilants, disinfectants and cleaners,
sterility assurance monitoring products for hospitals and dental
clinics, disposable infection control products primarily for dental
and GI endoscopy markets, dialysate concentrates, hollow fiber
membrane filtration and separation products, and specialty
packaging for infectious and biological specimens. Additionally, we
provide technical service for our products. For more
information, go to our website www.cantelmedical.com.
About Mar Cor Purification, Inc.
Mar Cor Purification,
Inc., a wholly-owned subsidiary of Cantel Medical Corp. (NYSE:CMN),
is a water purification company and is the largest supplier of
dialysis medical water systems in North
America. It has service facilities in 3 cities in
the United States and Canada including seven ion exchange resin
regeneration plants strategically located in Atlanta, Boston, Chicago, Philadelphia, San
Antonio, Montreal and
Toronto. Mar Cor also provides
turnkey water purification systems to high purity clients including
pharmaceutical, cosmetics, semiconductor and other bacteria
controlled applications. Unique hollow fiber filtration/separation
products and Peracetic acid (PAA) disinfectants are provided
through a worldwide distributor network. Visit our website at
www.mcpur.com to find out more about Mar Cor Purification.
http://www.mcpur.com/main/filtertech.html
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These statements involve a number of risks and uncertainties,
including, without limitation, the risks detailed in Cantel's
filings and reports with the Securities and Exchange Commission.
Such forward-looking statements are only predictions, and actual
events or results may differ materially from those projected or
anticipated.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cantel-medical-subsidiary-mar-cor-purification-given-510k-clearance-for-minncare-hd-disinfectant-for-use-in-water-system-disinfection-in-kidney-dialysis-applications-300021524.html
SOURCE Cantel Medical Corp.